N-Benzyl-N-(2-hydroxyethyl)-2-(oxazolidin-2-on-3-yl)-2-phenylacetamide
Abstract
:1. Introduction
2. Results
3. Experimental
Supplementary Materials
Author Contributions
Funding
Data Availability Statement
Conflicts of Interest
References
- Aitken, R.A.; Harper, A.D.; Inwood, R.A.; Slawin, A.M.Z. Access to diarylmethanols by Wittig rearrangement of ortho-, meta- and para-benzyloxy-N-butylbenzamides. J. Org. Chem. 2022, 87, 4692–4701. [Google Scholar] [CrossRef] [PubMed]
- Aitken, R.A.; Harper, A.D.; Inwood, R.A. Further studies on the [1,2]-Wittig rearrangement of 2-(2-benzyloxy)aryloxazolines. Molecules 2022, 27, 3186. [Google Scholar] [CrossRef] [PubMed]
- Wang, F.; Wang, J.; Zhang, Y.; Yang, J. The [1,2]- and [1,4]-Wittig rearrangement. Tetrahedron 2020, 76, 130857. [Google Scholar] [CrossRef]
- Yang, J.; Dudley, G.B. [1,2]-Anionic rearrangement of 2-benzyloxypyridine and related pyridyl ethers. J. Org. Chem. 2009, 74, 7998–8000. [Google Scholar] [CrossRef] [PubMed]
- Yang, J.; Wangweerawong, A.; Dudley, G.B. [1,2]-Wittig rearrangement of aromatic heterocycles. Heterocycles 2012, 85, 1603–1606. [Google Scholar] [CrossRef]
- Aitken, R.A.; Harper, A.D.; Slawin, A.M.Z. Rationalisation of patterns of competing reactivity by X-ray structure determination: Reaction of isomeric (benzyloxythienyl)oxazolines with a base. Molecules 2021, 26, 7690. [Google Scholar] [CrossRef] [PubMed]
- Poindexter, G.S.; Owens, D.A.; Dolan, P.L.; Woo, E. The use of 2-oxazolidinones as latent aziridine equivalents 2. Aminoethylation of aromatic amines, phenols and thiophenols. J. Org. Chem. 1992, 57, 6257–6265. [Google Scholar] [CrossRef]
- Etter, M.C.; MacDonald, J.C.; Bernstein, J. Graph-set analysis of hydrogen-bond patterns in organic crystals. Acta Crystallogr. Sect. B 1990, 46, 256–262. [Google Scholar] [CrossRef] [PubMed]
- Sheldrick, G.M. A short history of SHELXL. Acta Crystallogr. Sect. A 2008, 64, 112–122. [Google Scholar] [CrossRef] [PubMed] [Green Version]
D—H…A | D—H | H…A | D…A | D—H…A |
---|---|---|---|---|
O(23)–H(23)…O(7) | 0.974(11) | 1.798(11) | 2.7632(11) | 170.8(15) |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Aitken, R.A.; Logan, J.S.; Slawin, A.M.Z. N-Benzyl-N-(2-hydroxyethyl)-2-(oxazolidin-2-on-3-yl)-2-phenylacetamide. Molbank 2022, 2022, M1458. https://doi.org/10.3390/M1458
Aitken RA, Logan JS, Slawin AMZ. N-Benzyl-N-(2-hydroxyethyl)-2-(oxazolidin-2-on-3-yl)-2-phenylacetamide. Molbank. 2022; 2022(4):M1458. https://doi.org/10.3390/M1458
Chicago/Turabian StyleAitken, R. Alan, Joe S. Logan, and Alexandra M. Z. Slawin. 2022. "N-Benzyl-N-(2-hydroxyethyl)-2-(oxazolidin-2-on-3-yl)-2-phenylacetamide" Molbank 2022, no. 4: M1458. https://doi.org/10.3390/M1458
APA StyleAitken, R. A., Logan, J. S., & Slawin, A. M. Z. (2022). N-Benzyl-N-(2-hydroxyethyl)-2-(oxazolidin-2-on-3-yl)-2-phenylacetamide. Molbank, 2022(4), M1458. https://doi.org/10.3390/M1458